Imepitoin, formerly known as AWD 131-138 and ELB 138, is a novel partial BZD (benzodiazepine) receptor agonist that has the potential use as an antiepileptic drug for the treatment of canine idiopathic epilepsy.

L-655708 (FG-8094) is a novel and potent nootropic agent that acts as a subtype-selective inverse agonist at the α5 subtype of the benzodiazepine binding site on the GABAA receptor (Ki=0.45 nM).

NS11394 is a potent, selective and novel positive allosteric modulator of GABA(A) receptor.

ONO-8590580 is a novel and potent GABAAα5 negative allosteric modulator which enhances long-term potentiation and improves cognitive deficits in preclinical models.

FG 7142 (ZK 39106; LSU-65), a non-specificly benzodiazepine inverse agonist, has high affinity for the α1 subunit-containing GABAA receptor (Ki=91 nM).

Abecarnil (ZK112119; ZK-112119) is a positive allosteric modulator of GABAA receptor, acting as a ligand or a partial agonist for benzodiazepine (BZ) receptor with anxiolytic and anticonvulsant effects.

This product is discontinued due to commercial reason. Zuranolone (formerly known as SAGE-217; SAGE217) is an investigational drug being developed for the treatment of depressive disorders.

Baicalin is naturally occuring flavonoid glycoside found in several species in the genus Scutellaria, including Scutellaria lateriflora (blue skullcap).

(+)-Bicuculline (BRN-0098786; NSC-32192; BRN0098786; NSC32192), a phthalide-isoquinoline-based natural product isolated from Dicentra cucullaria, is a novel, light-sensitive and competitive antagonist of GABAA receptors with an IC50 of 2 μM.

Glabridin is a novel and potent GABA-A receptor modulator.